3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Colorectal Neoplasms
26
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
15
Head and Neck Neoplasms
13
Rectal Neoplasms
11
Colonic Neoplasms
11
Prostatic Neoplasms
8
Pancreatic Neoplasms
7
Mouth Neoplasms
6
Glioblastoma
6
Neuroblastoma
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Recurrence
4
Precancerous Conditions
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Liver Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Interventions
Etoposide
10
Cisplatin
9
Cyclophosphamide
7
etoposide phosphate
5
Paclitaxel
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
Carboplatin
5
fludarabine
4
Sirolimus
4
Gemcitabine
4
pembrolizumab
3
fludarabine phosphate
3
Sunitinib
3
Mesna
3
Melphalan
3
Filgrastim
3
Drug Therapy
3
Brentuximab Vedotin
3
Bleomycin
3
Bevacizumab
3
Automobiles
3
tremelimumab
2
sodium thiosulfate
2
pegfilgrastim
2
lutetium Lu 177 dotatate
2
durvalumab
2
Vorinostat
2
Stem Cell Transplantation
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Germ Cell and Embryonal
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled